Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	223	134	134	64	30	24
Market Cap Growth	66.88%	0.36%	107.29%	117.58%	23.40%	113.64%
Enterprise Value	250	157	161	98	66	62
Last Close Price	1.32	0.78	0.78	0.37	1.58	1.28
PE Ratio	108.06	14.93	71.42	77.29	17.20	11.47
PS Ratio	4.04	2.53	2.79	1.65	0.75	0.64
PB Ratio	3.97	2.53	3.12	1.60	-2.98	-2.06
P/TBV Ratio	17.69	17.21	78.88	-	-	-
P/FCF Ratio	-	-	-	-	13.52	17.47
P/OCF Ratio	-	28.90	470.51	19.27	7.21	8.42
EV/Sales Ratio	4.54	2.96	3.36	2.50	1.67	1.64
EV/EBITDA Ratio	24.96	17.28	19.44	19.70	12.35	9.88
EV/EBIT Ratio	49.85	29.91	34.11	24.01	14.66	11.97
EV/FCF Ratio	-	-	-	-	30.17	44.99
Debt / Equity Ratio	0.60	0.64	0.76	0.92	-3.76	-3.39
Debt / EBITDA Ratio	3.37	3.45	3.64	6.68	6.28	6.03
Debt / FCF Ratio	-	-	-	-	17.03	28.69
Asset Turnover	-	0.44	0.42	0.47	0.77	0.75
Inventory Turnover	-	1.52	1.93	2.18	2.70	2.96
Quick Ratio	-	0.56	0.66	0.70	0.35	0.67
Current Ratio	-	1.15	1.27	1.00	0.63	1.24
Return on Equity (ROE)	-	18.10%	4.74%	6.25%	-	-
Return on Assets (ROA)	-	2.73%	2.57%	3.04%	5.46%	6.46%
Return on Invested Capital (ROIC)	3.66%	7.08%	4.58%	4.02%	11.00%	12.99%
Return on Capital Employed (ROCE)	-	6.10%	6.00%	5.90%	38.60%	16.30%
Earnings Yield	1.47%	6.70%	1.40%	1.29%	5.82%	8.72%
FCF Yield	-	-3.73%	-2.82%	-50.06%	7.40%	5.72%
Dividend Yield	1.52%	2.58%	-	-	-	-
Buyback Yield / Dilution	-	-0.17%	-681.40%	-26.42%	-	-
Total Shareholder Return	1.54%	2.40%	-681.40%	-26.42%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.